(Sharecast News) - Life sciences company SkinBioTherapeutics traded sharply lower early on Monday after revealing an internal investigation had raised serious concerns over the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.
SkinBioTherapeutics said information received late on Friday had cast "significant...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE